Mimedx (MDXG) Revenue (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.05% |
| Dec 31, 2025 | 3.84% |
| Sep 30, 2025 | 15.33% |
| Jun 30, 2025 | 11.79% |
| Mar 31, 2025 | -5.06% |
| Dec 31, 2024 | 10.53% |
| Sep 30, 2024 | -3.61% |
| Jun 30, 2024 | 2.95% |
| Mar 31, 2024 | -2.44% |
| Dec 31, 2023 | 6.27% |
| Sep 30, 2023 | 0.56% |
| Jun 30, 2023 | 13.37% |
| Mar 31, 2023 | -3.63% |
| Dec 31, 2022 | 9.88% |
| Sep 30, 2022 | 1.21% |
| Jun 30, 2022 | 13.57% |
| Mar 31, 2022 | 15.90% |
| Dec 31, 2021 | -19.44% |
| Sep 30, 2021 | -7.47% |
| Jun 30, 2021 | 13.67% |
| Mar 31, 2021 | -12.52% |
| Dec 31, 2020 | 6.60% |
| Sep 30, 2020 | 19.86% |
| Jun 30, 2020 | -13.10% |
| Mar 31, 2020 | -19.19% |
| Dec 31, 2019 | -14.02% |
| Sep 30, 2019 | 31.77% |
| Jun 30, 2019 | 1.33% |
| Mar 31, 2019 | -28.12% |
| Dec 31, 2018 | 6.47% |
| Sep 30, 2018 | -8.86% |
| Jun 30, 2018 | 13.39% |
| Mar 31, 2018 | -4.22% |
| Dec 31, 2017 | 4.59% |
| Sep 30, 2017 | 4.36% |
| Jun 30, 2017 | 17.00% |
| Mar 31, 2017 | -1.55% |
| Dec 31, 2016 | 8.46% |
| Sep 30, 2016 | 12.36% |
| Jun 30, 2016 | 7.45% |
| Mar 31, 2016 | 2.96% |
| Dec 31, 2015 | 5.75% |
| Sep 30, 2015 | 7.30% |
| Jun 30, 2015 | 12.05% |
| Mar 31, 2015 | 3.02% |
| Dec 31, 2014 | 18.06% |
| Sep 30, 2014 | 31.07% |
| Jun 30, 2014 | 30.75% |
| Mar 31, 2014 | 8.70% |
| Dec 31, 2013 | 11.65% |
| Sep 30, 2013 | 19.25% |
| Jun 30, 2013 | 16.95% |
| Mar 31, 2013 | 9.96% |
| Dec 31, 2012 | 32.12% |
| Sep 30, 2012 | 62.86% |
| Jun 30, 2012 | 31.79% |
| Mar 31, 2012 | 40.62% |
| Dec 31, 2011 | 22.46% |
| Sep 30, 2011 | 11.54% |
| Jun 30, 2011 | 84.90% |